Are you worried about skin cancer?

A new drug might help fight advanced melanoma

"A very early test of an experimental drug seemed to slow the spread of advanced deadly skin cancer in a small study, the drug's U.S. developer reported in preliminary findings Wednesday.

Synta Pharmaceuticals Corp. of Lexington, Mass., reported that patients with advanced melanoma who got the drug survived an average of 3.7 months without new cancer lesions, compared to 1.8 months for those who got the standard treatment," reported the AP via Yahoo.

Are you worried about skin cancer? Rate you concern over skin cancer.